Genmab — Marts 2021
-
God morgen.
-
Asien: Stigninger næsten overalt efter Wall Street rekorder https://www.proinvestor.com/investornyt/673564/asien-stigninger-naesten-overalt-efter-wall-street-rekorder
-
Mandagens aviser med Danske Bank, Netcompany og Jyske Bank
https://www.proinvestor.com/investornyt/673565/mandagens-aviser-med-danske-bank-netcompany-og-jyske-bank -
Ja, det kan gå stærkt:
https://borsen.dk/nyheder/virksomheder/biotekaktie-styrtdykker-32-pct-efter-dumpet-studie -
Aktierne i den schweiziske storbank, Credit Suisse, falder mandag morgen med 10 pct. til 11,35 schweizerfranc.
Bankern oplyser at selskabet står til "meget alvorligt" (highly significant, red.) tab efter at en hedgefond,. der er kunde, ikke kan indbetale margin på investeringer. -
Klarussen.En forklaring på aflyst rally.
-
Se også mit link i Aktiesnakken samt vort newsfeed.
-
-
Who knew investment carries risc? Mogens Lykketoft?
-
The drug, now dubbed Abecma, will sport a list price of $419,500. / the bcma car-t https://endpts.com/bristol-myers-squibb-lands-once-high-stakes-approval-on-bcma-car-t-jj-is-breathing-down-its-neck/
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind